The Cannabist Company Holdings Inc.
CBSTFOTCHealthcare● Active
$0.03
+$0.00(+0.00%)
Market Cap$14475953
P/E Ratio—
52W High$0.16
52W Low$0.02
The Cannabist Company Holdings Inc. (CBSTF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBSTF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 10, 2025EPS Actual
-$0.03
Est. -$0.04 · +33.1%
Revenue
$0.08B
Est. $0.08B · +0.0%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 10, 2025
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
CBSTF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 18, 2026 | -$0.04 | — | — | — | $0.09B | — |
| ◌ Q2 FY2026 | Apr 15, 2026 | -$0.04 | — | — | — | $0.08B | — |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$0.04 | -$0.03 | +33.1% | $0.08B | $0.08B | +0.0% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.03 | -$0.16 | -454.0% | $0.09B | $0.08B | +10.1% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.04 | -$0.07 | -75.0% | $0.09B | $0.09B | -2.0% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -$0.04 | -$0.34 | -750.0% | $0.10B | $0.09B | +7.8% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.00 | -$0.00 | -99.5% | $0.11B | $0.11B | +5.0% |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$0.05 | -$0.03 | +40.0% | $0.13B | $0.13B | -1.7% |
Q2 FY2026
May 18, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 15, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.04
EPS Surpr.
+33.1%
Revenue
$0.08B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.16
EPS Est.
-$0.03
EPS Surpr.
-454.0%
Revenue
$0.09B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$0.07
EPS Est.
-$0.04
EPS Surpr.
-75.0%
Revenue
$0.09B
Q1 FY2025
Mar 11, 2025Miss
EPS Actual
-$0.34
EPS Est.
-$0.04
EPS Surpr.
-750.0%
Revenue
$0.10B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.00
EPS Est.
-$0.00
EPS Surpr.
-99.5%
Revenue
$0.11B
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.13B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q1 FY2026 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q4 FY2025 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2025 | $-0.04 | $-0.04 | $-0.04 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 10, 2025 | +33.1% | $0.07 | $0.07 | -2.05% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -454.0% | $0.09 | $0.10 | +7.14% |
| ▼ Q2 FY2025 | May 7, 2025 | -75.0% | $0.08 | $0.08 | +3.31% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -750.0% | $0.05 | $0.05 | -5.41% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -99.5% | $0.15 | $0.14 | -1.72% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +40.0% | $0.24 | $0.25 | +5.02% |
| ▼ Q2 FY2024 | May 9, 2024 | -60.0% | $0.31 | $0.29 | -5.88% |
| ▼ Q1 FY2024 | Mar 13, 2024 | -200.0% | $0.25 | $0.24 | -4.76% |
Q4 FY2025-2.05%
Report Date
Nov 10, 2025
EPS Beat/Miss
+33.1%
Price Before
$0.07
Price After
$0.07
Q3 FY2025+7.14%
Report Date
Aug 7, 2025
EPS Beat/Miss
-454.0%
Price Before
$0.09
Price After
$0.10
Q2 FY2025+3.31%
Report Date
May 7, 2025
EPS Beat/Miss
-75.0%
Price Before
$0.08
Price After
$0.08
Q1 FY2025-5.41%
Report Date
Mar 11, 2025
EPS Beat/Miss
-750.0%
Price Before
$0.05
Price After
$0.05
Q4 FY2024-1.72%
Report Date
Nov 7, 2024
EPS Beat/Miss
-99.5%
Price Before
$0.15
Price After
$0.14
Q3 FY2024+5.02%
Report Date
Aug 8, 2024
EPS Beat/Miss
+40.0%
Price Before
$0.24
Price After
$0.25
Q2 FY2024-5.88%
Report Date
May 9, 2024
EPS Beat/Miss
-60.0%
Price Before
$0.31
Price After
$0.29
Q1 FY2024-4.76%
Report Date
Mar 13, 2024
EPS Beat/Miss
-200.0%
Price Before
$0.25
Price After
$0.24
Avg Beat Reaction+1.48%
Avg Miss Reaction-1.22%
Beat Rate2 / 8 quarters
Largest Move+7.14% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBSTF ends December
The Cannabist Company Holdings Inc. (CBSTF) most recently reported earnings on November 10, 2025 for Q4 FY2025, posting EPS of $-0.03 — beating the analyst consensus of $-0.04 by +33.1%. The next CBSTF earnings date is expected around September 1, 2026.
Each quarter, investors track CBSTF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBSTF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBSTF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBSTF earnings · 5 questionsThe Cannabist Company Holdings Inc.'s next earnings report is expected around September 1, 2026. CBSTF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBSTF historically reports after market close (AMC).
CBSTF earnings datewhen is CBSTF earningsCBSTF next earnings datewhen does CBSTF report earningsCBSTF earnings calendar
▸ Source: FMP · The Cannabist Company Holdings Inc. SEC filings · US GAAP · The Cannabist Company Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026